Log in to save to my catalogue

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplanta...

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplanta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2830329631

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation

About this item

Full title

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation

Publisher

Ankara: Galenos Publishing House

Journal title

Ankara Ueniversitesi Tip Fakültesi mecmuasi, 2021-12, Vol.74 (3), p.337-342

Language

Formats

Publication information

Publisher

Ankara: Galenos Publishing House

More information

Scope and Contents

Contents

Objectives: Anti-thymos globulin (ATG) can potentially eliminate alloreactive donor T-cells and reduce the graft-versus-host disease (GVHD). As a result of this, increased disease relapse and reduced overall survival can be observed in ATG recipients. In addition, the presence of pre- allogeneic hematopoietic stem cell transplantation (allo-HSCT) m...

Alternative Titles

Full title

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2830329631

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2830329631

Other Identifiers

ISSN

1307-5608,0365-8104

E-ISSN

1307-5608

DOI

10.4274/atfm.galenos.2021.95866

How to access this item